
Obesity Drug Rollout Risks Creating a Two-Tier NHS System
It was meant to be a turning point for obesity care in the UK. Instead, the rollout of the new weight loss drug tirzepatide, known commercially as Mounjaro, is exposing deep fractures in the healthcare system.
Oct 31, 2025












